Ken Song, Founder of RayzeBio

Ken Song is the founder of RayzeBio. RayzeBio has raised $418M in total funding. Latest round: Series D. Based in San Diego, CA.

About Ken Song

Ken Song is the founder of RayzeBio, a Phase III oncology company that developed radiopharmaceutical therapies for cancer treatment. He led RayzeBio from its Series A financing through its acquisition by Bristol Myers Squibb for $4.1 billion. Song is now the founder of Candid Therapeutics, a new biotech company focused on autoimmune diseases that raised $370 million in 2024.

Ken Song at a glance

More founders in San Diego, CA (44)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library